Connect with us

Life Sciences

Health Innovators – Matthew Holt

At Frontiers Health 2022, pharmaphorum Editor in Chief Jonah Comstock sat down with Matthew Holt, the founder and
The post Health Innovators – Matthew…

Published

on

This article was originally published by PharmaPhorum

At Frontiers Health 2022, pharmaphorum Editor in Chief Jonah Comstock sat down with Matthew Holt, the founder and publisher of the Health Care Blog and a long-time self-described “digital health curmudgeon”.

In a freewheeling conversation, Jonah and Matt get into the nitty gritty of digital therapeutics and whether they should be following the paths of traditional therapeutics or blazing their own trail of new infrastructure.

For a long time, there was no debate on that topic, but as digital therapeutics have come into their own, DTx creators are questioning all the conventional wisdom, even as they take the steps they need to for regulation, reimbursement, and public trust.

They also talk about the age-old question of whether and how much AI can replace human physicians and therapists, now and in the future.

Check out the video below for the whole conversation, and stay tuned for more video interviews from Milan.

 

The post Health Innovators – Matthew Holt appeared first on .

therapeutics

Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending